|
|
|
|
서경 ( Seo Kyung ) - 연세대학교 의과대학 산부인과학교실
신해림 ( Shin Hai-Rim ) - 국립암센터
오진경 ( Oh Jin-Kyoung ) - 국립암센터 국가암관리사업지원평가연구단
|
|
Abstract
|
|
|
|
|
Objectives: Aim of study is to review efficacies of two human papillomavirus vaccines in different study populations and examine importance of HPV vaccine as a routine vaccine.
Methods: Four phase-3 efficacy studies of two HPV vaccines were reviewed. Magni-tude of efficacies were compared among different study populations.
Results: Recently, two kinds of papillomavirus (HPV) vaccines were developed. "Cer-varix" is a bivalent vaccine which contained L1 protein of HPV 16 and HPV 18, and "Gardasil" is a quadrivalent vaccine which contained L1 protein of HPV 6 and HPV 11 in addition. Efficacy study showed that both vaccine are highly effective to prevent cer-vical, vaginal and vulvar precancerous lesion in the population who are naive to HPV in-fection. Quadrivalent vaccine also showed high efficacy to prevent genital warts. Efficacy of the vaccine decreased in the general population who included both HPV-naive and HPV-infected peoples. Both vaccines showed high immune responses for 5 years after vaccination.
Conclusions: From the point of public health, HPV vaccine is an important vaccine for young adolescents who have not begun sexual activity. However, development of guide-lines for HPV vaccination for each country will be dependent on cost effectiveness of HPV vaccines of each population.
|
|
|
KeyWords
|
|
humanpapillomavirus, vaccine, efficacy
|
|
|
원문 및 링크아웃 정보
|
|
|
|
|
등재저널 정보
|
|
|
|
|
|
|